Literature DB >> 1669971

Toxicity equivalency factors for PCBs?

D Barnes1, A Alford-Stevens, L Birnbaum, F W Kutz, W Wood, D Patton.   

Abstract

In December 1990 the U.S. Environmental Protection Agency sponsored a workshop to discuss the applicability of an interim "toxicity equivalency factor" (TEF) approach to assessing risks posed by exposures to complex mixtures of polychlorinated biphenyls (PCBs). The group concluded that application of the TEF approach to PCBs would be less straightforward than it was in the case of chlorinated dibenzo-p-dioxins and dibenzofurans (CDDs/CDFs). It appears that "dioxin"-like properties of some PCB congeners are amenable to a TEF treatment that is compatible with that used for CDDs/CDFs. Such a scheme also seems to have utility in assessing risks to wildlife. Other non-"dioxin"-like toxic endpoints (e.g., neurotoxicity) appear to have a different structure-activity-related mechanism-of-action that requires a separate TEF scheme. The workshop identified data gaps in toxicology and analytical chemistry that hinder adoption of proposed TEF schemes for PCBs at this time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1669971

Source DB:  PubMed          Journal:  Qual Assur        ISSN: 1052-9411


  8 in total

Review 1.  The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds.

Authors:  Martin Van den Berg; Linda S Birnbaum; Michael Denison; Mike De Vito; William Farland; Mark Feeley; Heidelore Fiedler; Helen Hakansson; Annika Hanberg; Laurie Haws; Martin Rose; Stephen Safe; Dieter Schrenk; Chiharu Tohyama; Angelika Tritscher; Jouko Tuomisto; Mats Tysklind; Nigel Walker; Richard E Peterson
Journal:  Toxicol Sci       Date:  2006-07-07       Impact factor: 4.849

Review 2.  Stepping backward to improve assessment of PCB congener toxicities.

Authors:  L G Hansen
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 3.  The Ah Receptor: Adaptive Metabolism, Ligand Diversity, and the Xenokine Model.

Authors:  Mele N Avilla; Kristen M C Malecki; Mark E Hahn; Rachel H Wilson; Christopher A Bradfield
Journal:  Chem Res Toxicol       Date:  2020-04-07       Impact factor: 3.739

Review 4.  Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals.

Authors:  M J DeVito; L S Birnbaum; W H Farland; T A Gasiewicz
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

Review 5.  Endocrine effects of prenatal exposure to PCBs, dioxins, and other xenobiotics: implications for policy and future research.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1994-08       Impact factor: 9.031

6.  The mechanism of dioxin toxicity: relationship to risk assessment.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

7.  Developmental effects of dioxins.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

8.  The development of response surface pathway design to reduce animal numbers in toxicity studies.

Authors:  Sagita Dewi; Tore Aune; John A Aasen Bunæs; Adrian J Smith; Stig Larsen
Journal:  BMC Pharmacol Toxicol       Date:  2014-03-25       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.